Dr. Daniel McCabe Presents TCA Simulation
Dr. Dan McCabe discusses TCA Simulation.
Presenter
Daniel McCabe, MD
Clinical Assistant Professor, Emergency Medicine and Medical Toxicology - University of Iowa Hospitals and Clinics
Carver College of Medicine
Related Content
Jun 07, 2024
Xylazine, Illicit Drug Combo: Deadly Cocktail on the Rise
Emergency physicians must keep multiple things in mind when treating patients presenting with suspected xylazine exposure. First and foremost, it may be difficult to diagnose, as routine urine drug screens do not detect xylazine. Xylazine can be detected by chromatography-mass spectrometry testing. If exposure is suspected, naloxone should be administered to reverse any opiate co-ingestion. Physicians suspecting xylazine exposure are encouraged to report it to the FDA’s MedWatch Adverse Event Reporting Program.
